Why Is There So Much Fundraising for PAH? Pulmonary arterial hypertension is a rare “orphan” disease. The relatively small number of patients living with PAH means that they all need to band together to raise awareness, support each other and raise funds to further research in finding treatments and eventually a cure. What Are The Goals Of Fundraising for PAH? Pulmonary … [Read more...]
Zika Tips for Pulmonary Hypertension Patients
What is Zika? Zika is a virus spread via infected mosquitoes or from having sex with an infected individual. Most cases are being reported in South America but recently two neighborhoods in Miami, Florida have also been identified as having Zika carrying mosquitoes. Most people that are infected with Zika will not have much of an illness (perhaps some flu-like symptoms). … [Read more...]
Flu Vaccine for PAH Patients
It is hard to believe that summer is almost over and fall is about to begin. As kids get ready to go back to school we are reminded that it is time, once again, to think about getting the flu (influenza) vaccine. I know, this feels like setting out Christmas decorations before Halloween, but it is important for Pulmonary Hypertension patients to get the vaccine prior to the … [Read more...]
Is Pulmonary Arterial Hypertension a Heart Disease or a Lung Disease?
Yes. Pulmonary Arterial Hypertension is a disease that affects both the heart and lungs. The name means high pressure in the arteries of the lungs but it has severe consequences for both the heart and the lungs. How Does PAH Affect My Lungs? Pulmonary hypertension attacks the lungs in two ways. PAH causes vasoconstriction of the pulmonary arteries. The pulmonary arteries … [Read more...]
The TRITON Study is Up and Enrolling for PAH
New Study Comparing Medication Combinations in Treatment of Pulmonary Arterial Hypertension Actelion Pharmaceutics has undertaken an important new study that compares two medications versus three medications in patients that are newly diagnosed with PAH. Currently we can say with confidence that most patients do better when treated initially with an endothelin receptor … [Read more...]
